Fetal tachycardia: Mechanisms and predictors of hydrops fetalis  by Naheed, Zahra J. et al.
1736 Jc-C Vol. 27, No. 7 
June IYWxl716-40 
PEDIATRIC CARDIOLGGY 
Fetal Tachycardia: Mechanisms and Predictors of Hydrops Fetalis 
ZAHRA J. NAHEED, MD, JANEITE F. STRASBURGER, MD, FACC, 
BARBARA J. DEAL, MD, FACC, D. WOODROW BENSON, JR., MD, PtrD, 
SAMUEL S. GIDDING, MD 
flbjedns. This study had three ohjectii: 1) lo delcwiw the 
eketro- mecbauisms of fetat supnweulriculrr tachycar- 
die ot prosentatloa and postno- 2) to identity the clinieal sod 
ehdm&sii pdktors of hydmps ktslis; aud 31 to describe 
the medium-term fullmv-np (1 to 7 years) of patients with fetal 
Fetal 6upraventrienInr tachyedia cmtses signif- 
icant ktd and lwmatd tsmrlwy ntfd timalii. Premtal anal- 
*-JP@-J costirasetiopoffetolstlpmveelttrienlartaelly. 
C&lStorecbaplSllrShsvobecaItSUitC?d. 
snpraventrleuhv taehyenrdia tIlethuslsms were evol- 
Al the postnatal traosesopbsgePl ektrcphrsiologie pdore, 
tacltyardia was indud ia 27 of 30 patients; atriovea~ 
reentroat tocltycmlia in 25 (93%) of27 and imrimIrlol reentrant 
tacbyeardln ia only 2 (7%) of 27. &drops was present in 12 of 30 
fetuses. sustained wp4aventr&u&r tachycardia (>I2 II) KlJ 
Ioww geststtlou ot presetttfJti00 eatTe&Ied WitIt hydmps Ip c Q.oz, 
p < O.os), bat llwcbPntsss of tacilycnnJ& aad beml rate did Imt. 
Cestndonol age at deliveiy was 6igniEcantly g-enter in Umse wJt0 
recebed intrsutdne nmnrgrcseot (39 f 13 vs. 37 2 2.9 weeks, 
p = Ow4) despite ear&r presentdm (32.6 vs. 37.1 weeks). 
Cesarea0sectiondelivelieswereRducedintJlesfmle~(3of 
17 vs. 11 of 13, p = @&Jw). 
J:t &iowa@Wrr CO&I&II in 22 p&&s and supmventric- 
I&W tttehmrdia wJtJt et140ventriaJPr bbek (a&id Ratter) in 8 
Fetal supraventricular tachycardia is ‘are and frequently leads 
to the development of hydrops fetalis (l-3). Despite previous 
studii sbwing succe&l intrauterine antiarrhythmic drug 
therapy for fetal tachycardia, there continues to be- a high 
incidence of premature delivery, neonatal morbidity and mor- 
tality assofiated with this diagnosis (4J). ‘fhough choice of 
antiarrhythmic *dumpy is mechanism dependent (6), few stud- 
ies provide electrophysiologic analysis of fetal tachycardia 
(7-10). Because supraventricular tachycardia mechanisms vary 
with age at presentation, the frequency of the various su- 
pravemricular tachycardii mechanisms may bc different in the 
fetus (11). Of necessity, in utero mechanisms must be assessed 
by ttohmsiie means (l&-11). 
calcbrsions. Atriovebidar reentrant ta&ycardk~ was thr 
predominant nleelIaaism of suplaventricuhu tExhyedi0 in tJIe 
%tus. TJtere wos a high assoeiotioe of snpraventrtdtw tsebyepr- 
dia with atrioventrleul3r block in &ero and ncwsory a** 
CMLllfftioBs. Outeume at 1 to 7 years was exdJent 
E$Zss of severity of iUness at didd pwsentatiw. 
(d Am cd cpnliol1996;27:1736-4) 
Tne objectives of this study were 1) to determine e!ectr+ 
physiologic mechanisms of fetal supraventricular tachycardia 
at presentation and postnatally, 2) to identify the clinical and 
electrophysiologic predictors of hydrops fetalis, and 3) to 
descrii the outcome at medium-term follow-up of patients 
with fetal supraventricular tachycardia. 
Methods 
Study cnluut. The patient group consisted of 30 amsecu- 
tive neonates with documented fetal supraventricular tachycar- 
dia (fetal heart rate >2tXl beats/min) evaluated at our institu- 
tions between January 1, 1387 and November 30, 1993. 
Seventeen patients were prenatal referrals (prenatal group) 
and were managed at a tertiary care center by a multidisci- 
plinary obstetric and pediatric team. Thirteen patients were 
postnatal referrals (postnatal group) con&ii of neonates 
with a known history of fetal tachycardia referred for postnatal 
management. Ihe study inctuded both h@rnpic and nonhy- 
dropic fetuses. Hydrops fetalii was defined by the presence of 
&rid accumufaticn in two body cavities (fetal ascites, skin 
edema or pericarditti or pleural efIit&ma Clinkal c5urse was 
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reviewed from prenatal and postnatal records to determine the 
gestational age at onset of fetal tachycardia, presence of fetal 
hydrops, incidence of intrauterine antiarrhythmic treatment, 
mode of delivery, perinatal outcome and postnatal course. All 
patients had undergone a tramesophageal ekctrophysiologic 
procedure and at least 1 year of clinical follow-up. 
l@leebdsms uff5qmvenm taehyeanlia (prenatal vs. 
fm&uutnl). Prenatal fetal e&cardiograms, noninvasive elec- 
tronic fetal heart rate monitoring, neonatal electrocardiogram 
during tachycardia and postnatal transesophageal pacing pro 
cedures were reviewed to define the mechanism of tachycardia. 
In the postnatal group (n = 13). the mechanism of fetal 
tachycardia was deduced from surface electrocardiogran.s 
obtained within 24 h after emergent delivery for the indication 
of persistent fetal tachycardia. 
Based on prenatal and immediate postnatal characteristics, 
patients were divided into two groups: supravetttricular tachy- 
cardia with 1:l atrioventricufar conduztion and sttpraventriat- 
lar tachycardia with atrioventricular bio& Supraventricuiar 
tachycardia with 1:l atrioventricular cor~Iuction was diagnosed 
prenatally by the presence of a I:1 atrioveotricular contractiott 
sequence during tachycardia, abrupt onset and terminations 
and minimal heart rate v&ability. Supraventricular tachycar- 
dia with block was diagnosed prenatally by the presence of 
atrioventricular block during tachycardia on Doppler tlou 
analysis in the systemic veins, foramen ovale, and ventricular 
inflow/outflow regions as well as by direct observation of atrial 
wall contraction and stable atrial cycle length (7,g). Postnatal 
12-Cad e!t:?rocardiograms were obtained witbin 24 h of 
delivery, and mechanism was assigned as supraventricuhu 
t~hycardm with f:l at&ventricular conducttort or supraven- 
tricular tachycardia with variable atrioventricular block (atrial 
flutter). 
Postnatally, supraventriadar tachycardia was further di- 
vided into three major mechanii by e~logic cri- 
teria. 1) Atrioven:ncular reentrant tachyca& was defined as 
suftraventricular tachycardia with 1:l atrioventricular relation- 
ship and a ventriculoatriaf interval during trames@ageal 
pacing-induced tachycardia of >70 ms* (11). Locahxation of 
aazssoty connections was determined by prolongation of 
tachycardia cycle length and ventriculoatrial interval during 
ipsifateral bundle branch block (11). 2) Atrioventricular nodal 
reentrant tachycardia had a vemriculoatrial interval ~70 ms at 
tramesophageal procedure with exchtsion of evidence of an 
accessory connection (11). 3) fntraatrial reentrant tac&a&a 
was defined by presence of atrioventricular block during 
supraventricular tachycardia and pace initiation and termina- 
tion of atrial tachycardia 
Postnatal tramesophageal electrophysiologic procedure 
records were i-evked for age at procedure, interval from in 
utem presentation to tramesophageal pacing procedure+ in- 
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ducibility, mechanism and atrial and ventricular cycle lengths 
of supraventricular tachycardia. The extrastimulus testing pro- 
tocol has been described (I I). Median age at tramesophageal 
pacing procedure was 1 week. Mean interval from onset of 
fetal supraventrirular tachycardia to tramesophageal pacing 
procedure was 5 weeks (range <l to 205 weeks). 
In- treatmeut. Only fetuses with hydrops fetalis 
or chronic fetal tacbycardia with associated ventricular dys- 
function received intrauterine treatment. Transp!acental treat- 
ment was initially employed. In cases of advanced bydrops 
fetalis, abnormal biiysical profile or multiple drug failure. 
direct intratnuscular fetal tberapy with digoxin was employed. 
Co&centesis was not routinely used. Treatment strategy was 
identical for supraventricular tachycardia with ar.d without 
atrioventticular btock. Protocol induded the in’*ial use of 
digoxin, followed by addition of quintdine or verapamil. If 
ineffective, second-line drugs were &continued, and amioda- 
rone wss initiated. followed by drug combinations utilizing 
amiodamne. 
f&w- ta&yedh aulutcristies. Mechanism, du- 
ration and cycle length of tafhycardia were assessed, in corre- 
lation with hydrops fetalis. “Sustained” fetal supraveotrieular 
Mtyrzdii (at initial amessmenl) was defined as prolonged 
uninterrupted tacbycardia of >lth duration. Ta+zdia 
with intermittent sinus rhythm was de&ed as “mnuustaitted.” 
eawa~ Postnatal records were reviewed to deter- 
mine postnatal antiarrhythmii treatment, neonatal compiica- 
tioas, spontaneous tachycardia recurrences clinical outcome 
and intermediate term folkw-up. Supraventricular tachycardia 
was considered “dinMy q-0 t” ii i6 months had slap& 
with no epides of supmventricohu tachycardia. 
Data analysk To correlate cyde length of clinical tachy- 





presentation and at delivery for patients in the prenatal and 
postnatalmanagementgmupsweredetermmedusingthe 
unpairedrteaLogistic~wasperfomKdtodeter- 
mine whether g&at&n at presentaacion, medmmsm of tachy- 
car&*lengthordurationoft&ycardiamutemcorre- 
lated independently with hydmps fetalis The Pi&her exact test 
~usedtodeterminewhetbertertiarycare~ntof 







poattml gmup 37.1 t 3.0 weeks (p = Om?). ?lJe yolmpl 
fetus was 195 weeks at preseotaticm. AU patients had normal 
cardiaeanatomy. 
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!aprawttrkadar tachycardia with block (4 by echocardii 
graphic and 4 by ele&oc&iographic criteria). Twenty-seven 
of 30 patients had hlduciile suplaventlieulal tachycardia at tbe 
trwgeal pricing pmcedure; 3 were nouindueiie. Pre- 
ni3tdandpustltataltadrycardiam-wereconmldant 
in all tttrioventliadnl lecijmatiltg tacw (20 of 20) 
,ptients and in 2 (2 of 7) patients with intraatriaf reentrant 
tthyadia. Tite remaining live patientswitb supraventricnk 
m@cardia and atrioventriadar block had atrioventricular 
redproeating~atpostnatldtlansesophagealpacing 
pmcedure. Renatal and postnatal atrioventriadar re+ocat- 
ingmchy~dkcyckleq$bswere240+35a~230~30ms, 
respectively (r = 0.78. p < O.tlO5). In 19 patients with atrio 
ventricuhu reciprocating Whyca&ia, accessory connection 
tocaliFIltion by trans pacing procedure found acces- 
sory cxume&m to be left-sided in 16 and right-sided in 3. 
I%eexcitatiun was present on surface electrocardiogram within 
the Iirst year in 8 of 30 patients. No patients had atrioventric- 
ulal ntlde reentnurt tad&a&. 
In tbe &tee patients with noninducii supraventrkular 
Whycan& the intervals from presentation to transesophageal 
pa&tgprocedurewere5~11daysand9weeksOneof 
these three had clinical recurrence of atrioventtktdar recipro- 
awithin2weeks. 
wlthlqdswpa Tkelveof 
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Figure 1. Tbc mechanisms of prenatal fetat suprsventric- 
ulaltachycaldiibasedouplenataiandpostoataIuane- 
esophageal ekctrophysiologic evaluation in 30 patients 
are shown. AVRT = atrioventrkuIarreciprocatingtachy- 
cardia; IART = intraatrial reentrant tachycardia 
SW-AW = prenatal supraveotrictdar tachycardia with 
atrioventricular block; SVT-1:l = prenatal supraventricu- 
lar tachycardia with I:1 atrioventticuIar conduction; Lmld 
horders = prenatal diagnosis; Ii@ borders = postnatal 
diagnosis. 
with sustained tachycardia, 12 of 23 were hydropic compared 
to 0 of 7 fetuses without sustained tachycardia. There was no 
signifkant difference in the distriition of prenatal mecha- 
nisms between the hydropic and nonhydropic fetuses In the 
atrioventricular reciprocating taehycardia group with bydrops 
fetalis (n = 9). the mean prenatal tacbycmdia eyele length was 
240+30mscomparedwitb253~32msinthenonhydropic 
atrioventrictdar reciprocating tachycardii group (n = 13, p = 
0.17). Hydrops resolved after therapy in aft nine patients 
Lo&tic qression performed on chnical and electrophysi- 
dogic variables suggested that gestationat age at presentation 
(p = 0.05) and duration of ta&ycardia (p = 0.02) correlated 
independenUy with presence of fetal hydrops, but rne&a&m 
and ventricular cycle fength of tachycardia did not. 
periaatal sntbme. No mortality was encountered in either 
theprenatalorpostnatalgroup.Themeangestationalageat 
delivery in tbe prenatal group was 39.2 2 13 weeks, compared 
tothemeangestationala%eatdeliveryinthepostnatalgroug 
of 37.3 2 2.9 weeks (p = 0.64). All 13 patients in the postnati 
group were deliired emergently for the indiitiot~ of fetal 
~~llby- section,asopf.Wedto3of17 
cemrean section delivetks in the prenatal group @ = O.OtlMi), 
all 3 for obstetric indications other than fetal tachycardia. 
Eleven of 17 (prenatal group) and 2 of 13 (postnatal group) 
patients rcxeived intrauterine treatment (p = 0.01). Two . . 
cmpbhum of prenatal treatment occmred amkdarone- 
related reversible thyroid dy&mction and intramnsctdar 
digoxin-rekted supertieiat fetal laceration. In the postnatal 
group 2 of 13 had morbidity related to prematurity, and 1 
experienced an out-ofkspital eat&c arrest at 10 days of age 
while receiving empiric digoxin therapy before OUT evahtatior~ 
PostsrrQl ccnlme. poiitnatal follow-up ranged from 1.0 to 
7.25 years (mean 3.6 years). Twenty-three patkuts had dinid 
resolntionoftachycardiaby1yearofage.Therewasno 
signi6~tM~ncein~lloftacbycardiabetween 
fetuses with and without hydmps fetalis Patients with nonin- 
ducll auplaven~ at the 
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supraventricular tachycardia were not given prophylactic anti- 
arrhythmic treatment. With these criteria, 15 of 30 patients 
with fetal tachycardia avoided neonatal drug therapy, hrchrdmg 
5 of 30 neonates with documented rare episodes of postnatal 
tachyeardi Of the 13 patients treated in utero, only 5 received 
neonatal therapy. In 12 (52%) of 23 patients with clinical 
resolution by 1 year, follow-up extended beyond 3 years. One 
patient had late recurrence of atrioventricular reciprocating 
tachycardim after a tachycardia-free interval of 6 years 
Discussion 
The major findii of this study was that atrioventricular 
reciprocating tachycardia was the predominant mechanism of 
supraventricular tachycardia in the fetus. Supraventricular 
tachycardii with atrioventricular block in utero was associated 
with acaxory atrioventricuhu cormections in five of eight 
patients Hydrops fetalis was more likely in those with longer 
supraventricular tachycardia duration and earlier gestational 
age presentation but did not relate to supraventricular tachy- 
cardia medwnism or ventricular cyde length. Intrauterine 
therapy decreased perinatal morbidii. TB pac- 
ing allowed either no treatment or earfy diitbmation of 
antiarrhythmic treatment in 15 of 30 patients. Tbe medium- 
term outcome was excellent in both hydropic and nonhydropic 
fetuses with supraventricular tachycardii. 
fetus. It was present in 25 of 27 patients with induciie 
supraventriadar tachycardia. Five of seven patients with su- 
praventrictdar tachycudia and atrioventricular bfock had ac- 
cessory atrkwentricular connections The weiation between 
atriaf gutter and accessory atritwentriadar amneuks has 
pkousiy been observed (16-18). It has been shown tbat 
simultanews venbiculoatriat amtract& atrial diste&m and 
functional atrioventricuhu valve incompetence from annular 
enlargement ocurr during atrioventricuhu reciprocating t&y- 
cardia (3,19). We speculate that this may predispam the fetal 
or neonatal atrium to the development of intraatrial reentrant 
tachycardia and that the immature myomrdium may be 
uniquely susceptible to this phenomenon 
FctalVaspsBmtMfnf~ Eledrophysidogicand 
clinical features suggested a high degree of simkity between 
fetal and neoriatal v Tbeae features inch&d hi 
incidence of atrioventriadar reciprocating mchycardia dinical 
re-sohttion of supraventricufar ta&yca& e&odes in 77% of 
patientsbylyearofage,presenceofprerrdtatioaia26%d 
patients,highinc&nceoffeft-sidedaccemory~and 
evidence of late spontaneous mamemxs (20-22). 
. FIThcwSof Wails. PreGous studies have at- 
tempted to assess the factors correlating with the development 
of cmgesive heart failure in the fetus but have com3 to 
different condusions. Vaferius and Jacobsen (12) repor!ed 
increased incidence of hydmps fetalis with rates of supraven- 
tricdar tachycardia greater than 230 beati; however, 
Newburger and Keane (13) reported that neither the duration 
nor the heart rate was predictii of dii status at birth. 
Levkoff (14) reported that prolonged fetal tachycardm, even of 
several months’ duration, did not adversely affect the fetus. 
Zales et at. (15) demonstrated that neonates with prenatal 
hydrops fetalis secondary to supraventricutar tacbycardia ap- 
peared to develop heart failure from mu!riple episodes reeur- 
ring at relatively slow heart rates, whereas postnatal heart 
fake secondary to supraventrictdar tact:ycardii was caused 
by sustained episodes with relatively fast heart rates (15). nK 
results of our study are in agreement with those of Maxwell et 
al. (4), who demonstrated no correlation between heart rate 
(ventricular rate) or mechanism of fetal supraventricuhu 
tat@ and hydrops fetahs. But we also found a signifkant 
positive correlation of hydrops to “sustakd” duration of 
supravemriadar tachycardia. Conversely, the absence of sus- 
tained supraventriadar tachyc&a was uniformly correlated 
with absence of hydrops fetalis. We speculate that nomat+ 
mined brief episodes may not require intrauterine treatment. 
Prospective contfdfed shtdii to further de& this dpproach 
Renntnfieterwstions.Wefoundahighincktenceof 
premature int*n of pmgnancy related to fetal tachyem- 
diainthepopulationofpatientsneartermandmanaged 
outsidetertiatycarefacilitiesAhhoughpromptrefermlfor 








the prenatally referred group and the postnatagy referred 
grouP~shietlycomparable. 




agal pacing procedure. !3upsavemia&u ta&ycmb with 
block (atrial gutter) in the fetus was highly associated with 
atrioventrkular accemoq CoIIlKEtions. Althoq$ duration of 
suatainedtrrhyeardiaandgestationattac&xdkormetwere 
associated with hydrop fetalis, venttic&cyde Length and 
mechanismsofmchycu&werenot.Tertiarycaremauage- 
merit, iucl~ intrm.tterine drug therapy, appeared to de- 
creasemorbiirelatedtohydropfetakptematurityand 
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